CICI
REGN icon

Capital Investment Counsel Inc’s Regeneron Pharmaceuticals REGN Stock Holding History

Capital Investment Counsel Inc’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-288
Closed -$205K – 253
2024
Q4 		$205K Hold
288
– – 0.03% 182
2024
Q3 		$303K Hold
288
– – 0.04% 148
2024
Q2 		$303K Hold
288
– – 0.05% 146
2024
Q1 		$277K Hold
288
– – 0.05% 153
2023
Q4 		$253K Hold
288
– – 0.04% 152
2023
Q3 		$237K Sell
288
-125
-30% -$98.2K 0.05% 148
2023
Q2 		$297K Buy
413
+13
+3% +$10K 0.06% 135
2023
Q1 		$329K Hold
400
– – 0.08% 127
2022
Q4 		$289K Buy
400
+100
+33% +$73.8K 0.07% 134
2022
Q3 		$207K Sell
300
-100
-25% -$62.9K 0.06% 142
2022
Q2 		$236K Buy
400
+50
+14% +$32.5K 0.06% 149
2022
Q1 		$244K Buy
350
+25
+8% +$15.8K 0.05% 156
2021
Q4 		$205K Buy
+325
New +$200K 0.04% 178
2018
Q3 		– Sell
-725
Closed -$250K – 152
2018
Q2 		$250K Buy
+725
New +$227K 0.1% 126
2017
Q4 		– Sell
-525
Closed -$235K – 149
2017
Q3 		$235K Hold
525
– – 0.1% 130
2017
Q2 		$258K Sell
525
-50
-9% -$21.9K 0.11% 123
2017
Q1 		$223K Hold
575
– – 0.1% 135
2016
Q4 		$211K Sell
575
-385
-40% -$146K 0.1% 129
2016
Q3 		$386K Buy
+960
New +$385K 0.19% 95

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Investment Counsel Inc's REGN Position: Q1 2025 in Review

Capital Investment Counsel Inc sold out of Regeneron Pharmaceuticals (REGN) in Q1 2025, closing a stake of 288 shares — an estimated $205K sold.

Capital Investment Counsel Inc first reported a position in REGN in Q3 2016 and held it in 19 quarters. The position peaked at $386K in Q3 2016. 1,291 funds tracked by Wall St. Rank hold REGN as of Q1 2025.

  • Capital Investment Counsel Inc reported no remaining Regeneron Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Capital Investment Counsel Inc sold 288 Regeneron Pharmaceuticals shares in Q1 2025, an estimated $205K.
  • Capital Investment Counsel Inc first reported a position in Regeneron Pharmaceuticals in Q3 2016 and held it in 19 quarters.
  • Capital Investment Counsel Inc's Regeneron Pharmaceuticals position peaked at $386K in Q3 2016.
  • 1,291 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2025.

Based on Capital Investment Counsel Inc's 13F filing for Q1 2025, filed 28 Apr 2025.